Fintel reports that on November 18, 2024, Needham downgraded their outlook for Biogen (SNSE:BIIBCL) from Buy to Hold.
What is the Fund Sentiment?
There are 1,773 funds or institutions reporting positions in Biogen. This is an decrease of 52 owner(s) or 2.85% in the last quarter. Average portfolio weight of all funds dedicated to BIIBCL is 0.22%, an increase of 12.77%. Total shares owned by institutions decreased in the last three months by 1.12% to 146,895K shares.
What are Other Shareholders Doing?
Primecap Management holds 16,315K shares representing 11.20% ownership of the company. In its prior filing, the firm reported owning 16,338K shares , representing a decrease of 0.14%. The firm decreased its portfolio allocation in BIIBCL by 15.20% over the last quarter.
BlackRock holds 15,347K shares representing 10.53% ownership of the company.
VPMCX - Vanguard PRIMECAP Fund Investor Shares holds 9,155K shares representing 6.28% ownership of the company. In its prior filing, the firm reported owning 9,154K shares , representing an increase of 0.02%. The firm increased its portfolio allocation in BIIBCL by 3.63% over the last quarter.
Wellington Management Group Llp holds 5,131K shares representing 3.52% ownership of the company. In its prior filing, the firm reported owning 5,166K shares , representing a decrease of 0.69%. The firm decreased its portfolio allocation in BIIBCL by 88.57% over the last quarter.
Jpmorgan Chase holds 5,102K shares representing 3.50% ownership of the company. In its prior filing, the firm reported owning 4,715K shares , representing an increase of 7.59%. The firm decreased its portfolio allocation in BIIBCL by 94.34% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
